Centers for Disease Control and Prevention | Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera |
---|---|
When vaccine is limited, who should get vaccinated first? V-safe after vaccination health checker | Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations |
Centers for Disease Control and Prevention | Benefits of getting a COVID-19 vaccine |
---|---|
FDA for emergency use authorization | Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine |
Centers for Disease Control and Prevention.
28Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers | Vaccine adverse event reporting system VAERS |
---|---|
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |